Accuray | ARAY - Gross Profit On Sales


Accuray reported $41.89M in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 44.78M 2.93M Sep/2025
Artivion USD 73.14M 1.25M Dec/2025
AtriCure USD 109.31M 3.97M Mar/2026
Boston Scientific USD 3.61B 64M Mar/2026
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Inogen USD 41.34M 1.39M Sep/2024
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 153.28M 4.76M Dec/2025
Surmodics USD 20.08M 31.62M Jun/2025
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Trinity Biotech USD 6.47M 1.59M Sep/2025